May Flashcards
Translational Chemistry
when a particular substance exhibits biological activity
starts with the chemistry
Translational Biology/ Medicine
observation of biological property/ concept- manipulated for therapeutic benefit
based on a specific clinical observation
Substance for translational chemistry
d-tubocurarine
antagonist at nicotinic ACh receptors
used in open chest surgery to paralyse the diaphragm
drug found from library based
warfarin- lead to tipranavir
drug found in ligand-based
LNFPI (peptide) lead to saquinivir
drug found in structure-based
Ritanovir- symmetrical
pharmacophore
part of molecular structure that is responsible for biological/ pharmacological interaction
approaches for ligand based discovery
- based on a known ligand (endogenous based design)
- based on an initial hit (prototype based design)
- based on a known drug (analogue based design)
how to increase diversity of a library
- collect from natural sources
- traditional medicines (Chinese)
- combinatatorial chemistry- computer slightly changes a molecule so related but different
- in silicon library screening
lipinskis rule of 5
- molecular mass <500 Da
- LogP <5
- <5 hydrogen bond donors
- sum of Ns and Os less than 10
Caco-2 monolayers
see if it can cross the surface of the GIT
Caco-2 cells mimic enterocytes
form gap junctions
Hepatic microsomal CYP
tests metabolism- phase 1 reactions
endosomes are homogenised and form microsomes which contain CP450 enzymes
Hepatic Culture
see if liver cells metabolise compounds
phase 2 reactions
how much is being absorbed and any conjugates produced
recombinant processes
manipulate the processes of transcription, translation and replication to produce enough protein to carry out screens
Intron
non-coding bit of DNA
removed during post-transcriptional modification by splicing
polyadenylation
long tail of A’s which are important for stability of RNA
promotor
signal that the following regions need to be transcribed
cDNA
made in vitro from mRNA from isolated cells and expresses the target protein
contains no introns
made using reverse transcriptase
multiple cloning site
has unique restriction sites so the rest of the plasmid will be left untouched
has symmetry so is rare
restriction enzymes- cleave phosphodiester bond- cut the covalent bond in the backbone
EcoR1
creates 5’ sticky end
retains a phosphate group
Pst1
creates 3’ sticky end
the ends have an OH- group
EcoRV
creates blunt ends
less useful as cuts right in the middle
alkaline phosphatase
removes the 5’ end so the plasmid cannot re-anneal
T4PNK
phosphorylates the 5’ end
important for when insert is synthesised in PCR
stain for gel electrophoresis
ethidium bromide
intercalates between base pairs in double helix
fluoresces under UV light
ColE1 origin of replication
used to tell the bacteria to replicate the plasmid
antibiotic resistance gene
used so only the bacteria with the insert will survive
site directed mutagenesis
changing a protein and observing the change in pharmacology
used for interpreting and understanding the molecular nature of the drug-target interaction
pharmacogenetics
genetic variations revealed by clinically used drugs
how genes affects body’s reactions to drugs
pharmacogenomics
Development of new drugs from the discovery of new genes, possibility of creating personalised drugs for individuals based on their own genetic makeup
Succinylcholine sensitivity
neuromuscular blocking agent used in surgery
apnoea- won’t be able to breathe for themselves
prolonged paralysis
sensitivity in autosomal recessive
tandem repeat
small section of genome repeated
e.g. Huntington’s disease- expansion of tandem repeat
copy number variation
several copies of a large part of the genome e.g. 3/4 copies of a gene
SNP
single nucleotide alteration
1- change nucleic acid and amino acid
2- change in nucleic acid but no change in amino acid
next generation sequencing
sequencing the whole genome
epigenetic marks
changes within the genome that affect gene expression but are not based on changes in the DNA sequence
absorption
movement of drug from site of action to systemic circulation
bioavailability
measurement of rate and extent to which drug reaches systemic circulation
applies to all routes of administration